02.19.21
Pfizer seeks to store vaccine at higher temperatures, easing logistics

FRANKFURT (Reuters) – Pfizer Inc and BioNTech SE have asked the U.S. health regulator to relax requirements for their COVID-19 vaccine to be stored at ultra-low temperatures, potentially allowing it to be kept in pharmacy freezers. Approval by the Food and Drug Administration (FDA) could send a strong signal to other regulators around the world